Skip to main content
Top
Published in: Rheumatology International 5/2019

Open Access 01-05-2019 | Abatacept | Correction

Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis

Authors: Vivian P. Bykerk, Gerd R. Burmester, Bernard G. Combe, Daniel E. Furst, Tom W. J. Huizinga, Harris A. Ahmad, Paul Emery

Published in: Rheumatology International | Issue 5/2019

Login to get access

Excerpt

The article “On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis”, written by Vivian P.Bykerk, was originally published Online First without open access. After publication in volume [38], issue [12], page [2225–2231] the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. …
Metadata
Title
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
Authors
Vivian P. Bykerk
Gerd R. Burmester
Bernard G. Combe
Daniel E. Furst
Tom W. J. Huizinga
Harris A. Ahmad
Paul Emery
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 5/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4232-9

Other articles of this Issue 5/2019

Rheumatology International 5/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.